Central serous chorioretinopathy following intramuscular testosterone therapy in prolactinoma
Oxford Medical Case Reports · 08.06.2026 · 2026 (6)
DOI: 10.1093/omcr/omag105 ↗Kurz gefasst
Fallbericht in der Zeitschrift Oxford Medical Case Reports, online erschienen am 21.06.2026. Verfasst von Vivek Jha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER), Sector 12, Chandigarh 160012, Chandigarh, India. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER), Sector 12, Chandigarh 160012, Chandigarh, India.
- Centre for Endocrinology, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, United Kingdom.
- Department of Ophthalmology, Postgraduate Institute of Medical Education and Research (PGIMER), Sector 12, Chandigarh 160012, Chandigarh, India.
ORCID-Profile: Vivek Jha, Pinaki Dutta, Ashley B Grossman
Zitieren
APA
Jha, V., Dutta, P., Grossman, A. B., & Bashyal, B. (2026). Central serous chorioretinopathy following intramuscular testosterone therapy in prolactinoma. Oxford Medical Case Reports, 2026(6). https://doi.org/10.1093/omcr/omag105
Vancouver
Jha V, Dutta P, Grossman AB, Bashyal B. Central serous chorioretinopathy following intramuscular testosterone therapy in prolactinoma. Oxford Medical Case Reports. 2026;2026(6). doi:10.1093/omcr/omag105
BibTeX
@article{Jha2026,
author = {Jha, Vivek and Dutta, Pinaki and Grossman, Ashley B and Bashyal, Byanjana},
title = {Central serous chorioretinopathy following intramuscular testosterone therapy in prolactinoma},
journal = {Oxford Medical Case Reports},
year = {2026},
volume = {2026},
number = {6},
doi = {10.1093/omcr/omag105}
}
EUVIMED